February 1, 2018
Faron to kick off developing Clevegen for cancer, as it got patent for its antibodies from European Patent Office
Faron Pharmaceuticals has gotten a patent from European Patent office, for Clever-1 antibodies, the mechanism for the Clevegen, the treatment…